Axonics, Inc.
AXNXDelisted Nov 15, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001603756
Axonics, Inc. was delisted on Nov 15, 2024; its insiders filed their last Form 4 on Nov 15, 2024; 233 institutions reported holding it in 13F filings for Q3 2024, worth $3.54B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Axonics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Axonics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Carrel Michael H | Director | 0 | Nov 15, 2024 | 0 |
| Cohen Raymond W | Chief Executive Officer | 0 | Nov 15, 2024 | 0 |
| Ford Alfred J Jr | Chief Commercial Officer | 0 | Nov 15, 2024 | 0 |
| Kiernan Jane E | Director | 0 | Nov 15, 2024 | 0 |
| McNamara Robert | Director | 0 | Nov 15, 2024 | 0 |
| Demski David M | Director | 0 | Nov 15, 2024 | 0 |
| snyderman nancy lynn MD | Director | 0 | Nov 15, 2024 | 0 |
| Noblett Karen | Chief Medical Officer | 0 | Nov 15, 2024 | 0 |
| Sama Rinda | Chief Operating Officer | 0Indirect | Nov 15, 2024 | 0 |
| Woock John | EVP, Chief Mktg/Strtgy Officer | 0 | Nov 15, 2024 | 0 |
| Lopez Esteban | Director | 0 | Nov 15, 2024 | 0 |
| Keese Kari Leigh | Chief Financial Officer | 0 | Nov 15, 2024 | 0 |
| Dearen Danny L. | President & CFO | 23,777 | Oct 3, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2022 (view filing) | Feb 3 | Same day | Cohen Raymond WChief Executive Officer | SSale | −35.1K | $48.25 | −$1.69M | −9.4%339.6K after | 2 lots |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Dearen Danny L.See Remarks | SSale | −20.0K | $50.93 | −$1.02M | −66.7%10.0K after | 4 lots |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Woock JohnChief Marketing Officer | SSale | −5.00K | $60.48 | −$302.4K | −16.7%24.9K after | 2 lots |
| Sep 13, 2021 (view filing) | Sep 9 | 4 days | Cohen Raymond WChief Executive Officer | SSale | −50.0K | $77.11 | −$3.86M | −17.6%234.6K after | |
| Sep 3, 2021 (view filing) | Sep 1-2 | 2 days | Woock JohnChief Marketing Officer | SSale | −10.0K | $74.86 | −$748.6K | −28.6%24.9K after | 2 lots |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Woock JohnChief Marketing Officer | SSale | −25.0K | $67.00 | −$1.68M | −45.5%29.9K after | 4 lots |